<DOC>
	<DOC>NCT00524927</DOC>
	<brief_summary>This study aims to provide further supportive evidence that Methoxyflurane, a potent analgesic, administered using the Penthrox Inhaler is safe and efficacious in adult participants, specifically those who experience incident pain associated with a planned bone marrow biopsy.</brief_summary>
	<brief_title>Safety and Efficacy of Methoxyflurane for Treatment of Incident Pain</brief_title>
	<detailed_description />
	<mesh_term>Methoxyflurane</mesh_term>
	<criteria>Adult participants (18 years of age or older) Able to give written informed consent Anticipated episode(s) of incident pain related to planned BMB lasting no more than 30 minutes on average Anticipated life expectancy of at least 1 month Pre Subjects with a clinical condition that may, in the opinion of the investigator, impact on the subject's ability to participate in the study, or on the study results Participants who have had IV sedation/opioid on previous BMB and who wish to receive IV sedation/opioid on this occasion or who in the opinion of the BMB operator would be advised to receive IV sedation/opioid on this occasion Concomitant use of other investigational agents Concomitant use of nephrotoxic agents such as gentamicin Uncontrolled INR (&gt;4) Personal or familial hypersensitivity to fluorinated anaesthetics Personal or familial malignant hyperthermia Respiratory rate of less than 10 per minute Has previously received methoxyflurane Known preexisting renal or hepatic impairment Compromised Renal Function (creatinine ≥ 1.5 x ULNR) Compromised Liver Function (bilirubin ≥ 2.5 x ULNR) Premedication with anxiolytic (e.g. midazolam, diazepam) Dosed with breakthrough dose of analgesic that may contribute to control of pain during the planned procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Incident Pain</keyword>
	<keyword>Bone Marrow Biopsy</keyword>
</DOC>